Prox Ventures logo

Prox Ventures

Asia, Shanghai, China, Shanghai

Description

Prox Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies.

Investor Profile

Prox Ventures has made 11 investments, with 4 in the past 12 months and 18% as lead.

Stage Focus

  • Series A (45%)
  • Seed (36%)
  • Series E (9%)
  • Series Unknown (9%)

Country Focus

  • United States (55%)
  • China (36%)
  • Singapore (9%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Therapeutics
  • Manufacturing
  • Life Science
  • Oncology
  • Esports
  • Fashion
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Prox Ventures frequently co-invest with?

SeedFolio
North America, California, United States, San Diego
Co-Investments: 2
SP
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Bridge Point Capital
North America, New York, United States, New York
Co-Investments: 1
AIM-HI Accelerator Fund
North America, Maryland, United States, Rockville
Co-Investments: 1
Creative Ventures
North America, California, United States, Oakland
Co-Investments: 1
Norwest Venture Partners
North America, California, United States, Palo Alto
Co-Investments: 1
Partners Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
KreaMedica
North America, Quebec, Canada, Montréal
Co-Investments: 1
Gaorong Capital
Asia, Beijing, China, Wangjing
Co-Investments: 1
Gemseki
Asia, Tokyo, Japan, Akasaka
Co-Investments: 1

Which angels does Prox Ventures often collaborate with?

JB
North America, North Dakota, United States, Fargo
Shared Deals: 1

What are some of recent deals done by Prox Ventures?

Tuanxiang Pharmaceutical

Shanghai, Shanghai, China

Tuanxiang Pharmaceutical is an innovative drug research and development company.

Health CarePharmaceuticalProduct Research
SeedFeb 24, 2025
LinkZill

Hangzhou, Zhejiang, China

LinkZill is a high-tech firm with products such as organic semiconductor materials, thin-film transistors, array, and portable test systems.

Advanced MaterialsElectronicsManufacturingSemiconductor
Series AFeb 14, 2025
iVIEW Therapeutics

Doylestown, Pennsylvania, United States

IVIEW Therapeutics is an ophthalmology drug development company that focuses on the treatment of viral conjunctivitis.

BiotechnologyHealth CareMedicalMedical DeviceTherapeutics
Series AJan 17, 2025
Chentai New Materials

Suzhou, Jiangsu, China

Chentai New Materials integrates the R&D, design, manufacturing, and sales of high-performance composite ceramics.

Innovation ManagementManufacturingMedicalSales
Series ADec 16, 2024
Amount Raised: $13,729,663
Cytonus Therapeutics

Carlsbad, California, United States

Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte

BiotechnologyHealth CareMedical
Series ANov 3, 2023
Amount Raised: $11,703,095
DotBio

Singapore, Central Region, Singapore

DotBio develops multi-functional antibodies based on its proprietary DotBody technology as the next generation of cancer therapies.

BiotechnologyLife ScienceMedical
SeedAug 7, 2023
Amount Raised: $5,600,000
Cytonus Therapeutics

Carlsbad, California, United States

Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte

BiotechnologyHealth CareMedical
Series UnknownFeb 28, 2023
VerImmune

Baltimore, Maryland, United States

VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection.

BiotechnologyHealth CareOncologyTherapeutics
SeedJul 27, 2022
Amount Raised: $2,500,000
Clerio Vision

Rochester, New York, United States

Clerio Vision is developing a revolutionary product platform for the global ophthalmic market.

BiotechnologyHealth CareMedicalMedical Device
Series EFeb 3, 2021
Amount Raised: $12,500,000
PercAssist

Santa Clara, California, United States

PercAssist develops percutaneous balloon catheters to improve left ventricular function and myocardial recovery.

Health CareHealth DiagnosticsMedical Device
SeedJan 1, 2021